New combo pill aims to tame stubborn high blood pressure
NCT ID NCT06682000
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tested whether adding a second drug (DWC202314) to an existing one (DWC202404) helps people whose high blood pressure isn't controlled by the first drug alone. 192 adults with essential hypertension took part. The study is now complete, and results will show if the combination lowers blood pressure more effectively.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DWC202404 and DWC202314 (combination drug therapy)
What this could lead to
If successful, this combination could offer a new treatment option for people with high blood pressure that isn't well controlled by a single medication.
What could go wrong
This is a completed Phase 3 trial, but results are not yet public. The combination may not prove significantly better than existing treatments, and side effects are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanyang University Medical Center
Seoul, South Korea